Skip to main content
FinSpry Logo
FinSpry
CBIO logo
CBIO
(NASDAQ)
Crescent Biopharma, Inc.
$16.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Crescent Biopharma, Inc. (CBIO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Crescent Biopharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$31.00
↑ 82.46% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CBIO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Stephen Willey
Stifel Nicolaus
BuyMaintains
$30.00
Robert Driscoll
Wedbush
BuyMaintains
$27.00
Mitchell Kapoor
HC Wainwright
HoldDowngrades
-
Biren Amin
Piper Sandler
BuyMaintains
$35.00
Charles Zhu
LifeSci Capital
BuyMaintains
$22.00 → $28.00
Bradley Canino
Guggenheim
BuyMaintains
$35.00
Phil Nadeau
TD Cowen
BuyMaintains
-
Bradley Canino
Guggenheim
BuyMaintains
$35.00
Phil Nadeau
TD Cowen
BuyMaintains
-

Frequently Asked Questions

What is the analyst consensus rating for CBIO?

The analyst consensus rating for CBIO is "Buy" based on 7 analyst recommendations.

What is the average price target for CBIO?

The average 12-month price target for CBIO is $31.00, representing an upside of 82.5% from the current price of $16.99.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.